MENU
UNCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Unicycive Therapeutics (UNCY) Earnings Date & Reports
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease... Show more
A.I. Advisor
published Earnings
UNCY is expected to report earnings to rise 478.33% to -34 cents per share on November 18
Q3'26
Est.
$-0.35
Q2'26
Beat
by $0.42
Q1'26
Missed
by $0.66
Q4'25
Missed
by $0.65
Q3'25
Missed
by $0.26
The last earnings report on August 12 showed earnings per share of -5 cents, beating the estimate of -47 cents. With 469.50K shares outstanding, the current market capitalization sits at 129.25M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1975 W. El Camino Real
Phone
+1 650 351-4495
Employees
22
Web
https://www.unicycive.com